Michelle Linterman received her PhD in Immunology from the Australian National University in Canberra, where she investigated a novel mechanism of immunological tolerance; a phenomenon by which the immune system fails to respond to an antigen. She is currently a Group Leader at the Babraham Institute and her principle research focus is on how the immune system responds to vaccination.

Learn more about Michelle in this People & Ideas article published in the Journal of Experimental Medicine in June 2023: Michelle Linterman: We are always learning